Table 1

Patient characteristics (n = 13)

Men6 (46%)
Women7 (54%)
Median age (range)60 (46–74)
Karnofsky performance status:
 90%10 (77%)
 80%2 (15%)
 70%1 (8%)
Stage
 Limited5 (38%)
 Extensive8 (62%)
Chemotherapy
 Etoposide, cisplatin12 (92%)a
 Etoposide, carboplatin1 (8%)
Response to initial therapy
 Complete2 (15%)
 Partial11 (85%)
Radiation
 Thoracic6 (46%)
 Brainb7 (54%)
 None4 (31%)
  • a One patient received 4 cycles of etoposide, cisplatin and 2 cycles etoposide, carboplatin.

  • b Brain radiation was administered to treat brain metastases in 4 patients, and for prophylaxis in 3 patients.